Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

The Prognostic Impact Of Complex Gene Mutation In The Intermediate Risk Karyotype Acute Myeloid Leukemia

Satoshi Wakita, MD, PhD, Hiroki Yamaguchi, MD, PhD, Takeshi Ryotokuji, MD, Tuneaki Hirakawa, MD, PhD, Ikuko Omori, Tomoaki Kitano, Kunihito Arai, Yoshio Mitamura, Fumiko Kosaka, Kazuo Dan, MD, PhD, Koiti Inokuchi, MD, PhD

Blood (2013) 122 (21): 1418.

https://doi.org/10.1182/blood.V122.21.1418.1418

Published: 2013

Journal Articles

Inhibition Of S100A6 Induces Graft Versus Leukemia Effects In MLL/AF4-Positive ALL In Human PBMC-SCID Mice

Hayato Tamai, MD, Hiroki Yamaguchi, MD, PhD, Kazuo Dan, MD, PhD, Koiti Inokuchi, MD, PhD

Blood (2013) 122 (21): 2016.

https://doi.org/10.1182/blood.V122.21.2016.2016

Published: 2013

Journal Articles

B7-H1 Molecules on Myeloma Cells Induce Aggressive Cell Behavior

Hideto Tamura, MD, PhD, Mariko Ishibashi, PhD, Taishi Yamashita, PhD, Asaka Kondo, MD, PhD, Namiko Okuyama, MD, Hideya Hyodo, MD, PhD, Yasuko Hamada, MD, Kazuo Dan, MD, PhD, Lieping Chen, MD, PhD, Kiyoyuki Ogata

Blood (2011) 118 (21): 474.

https://doi.org/10.1182/blood.V118.21.474.474

Published: 2011

Journal Articles

The Clinical Features and Prognostic Impact of DNMT3A Gene Mutation in Japanese Patients with De Novo AML

Takeshi Ryotokuji, MD, Hiroki Yamaguchi, MD, PhD, Ikuko Omori, Tuneaki Hirakawa, MD, PhD, Satoshi Wakita, MD, Tomoaki Kitano, Yoshio Mitamura, Fumiko Kosaka, Takashi Shimada, MD, PhD, Koiti Inokuchi, MD, PhD, Kazuo Dan, MD, PhD

Blood (2011) 118 (21): 2537.

https://doi.org/10.1182/blood.V118.21.2537.2537

Published: 2011

Journal Articles

Gene Mutations in Paired Initial Presentation and Relapse Samples From Acute Myeloid Leukemia Patients,

Satoshi Wakita, MD, Hiroki Yamaguchi, MD, PhD, Yoshio Mitamura, Fumiko Kosaka, Takashi Shimada, MD, PhD, Koiti Inokuchi, MD, PhD, Kazuo Dan, MD, PhD

Blood (2011) 118 (21): 3592.

https://doi.org/10.1182/blood.V118.21.3592.3592

Published: 2011

Journal Articles

MLL/AF4 Positive Acute Lymphoblastic Leukemia Has Resistance to Tumor Necrosis Factor-Alpha Caused by up-Regration of S100A6

Hayato Tamai, MD, Koichi Miyake, MD, PhD, Hiroki Yamaguchi, MD, PhD, Masahiro Okabe, MD, Kazuo Dan, MD, PhD, Koiti Inokuchi, PhD, MD, Takashi Shimada, MD, PHD

Blood (2010) 116 (21): 2477.

https://doi.org/10.1182/blood.V116.21.2477.2477

Published: 2010

Journal Articles

The Activated K-RAS Protein Accelerates Human Derived-MLL/AF4 Induced Leukemo-Lymphomogenicity In Transgenic Mice Model

Hayato Tamai, MD, Koichi Miyake, MD, PhD, Miyuki Takatori, Noriko Miyake, Hiroki Yamaguchi, MD, PhD, Kazuo Dan, MD, PhD, Takashi Shimada, MD, PHD, Koiti Inokuchi, PhD, MD

Blood (2010) 116 (21): 61.

https://doi.org/10.1182/blood.V116.21.61.61

Published: 2010

Journal Articles

Identification and Functional Characterization of Telomerase RNA Variant Alleles in Japanese Patients with Aplastic Anemia or Myelodysplastic Syndrome.

Junko Takeuchi, MD, Ly Hinh, PhD, Beauchamp Adam, PhD, Koiti Inokuchi, MD, PhD, Fumiko Kosaka, Kazuhiro Sawaguchi, Yoshio Mitamura, Ayako Watanabe, MD, PhD, Seiji Gomi, MD, PhD, Hiroki Yamaguchi, MD, PhD, Kazuo Dan, MD, PhD

Blood (2006) 108 (11): 977.

https://doi.org/10.1182/blood.V108.11.977.977

Published: 2006

Journal Articles

Hematopoietic Differentiation of ES Cells from P230 Bcr/Abl Transgenic Mouse.

Sakae Tanosaki, MD, PhD, Koiti Inokuchi, MD, PhD., Kazuhiro Sawaguchi, Jyunko Takeuchi, MD., Masato Tamai, MD., Naoya Uchida, MD., Ayako Watanabe, MD., Mituharu Inami, MD., Hiroki Yamaguchi, MD, PhD., Kazuo Dan, MD, PhD.

Blood (2005) 106 (11): 4331.

https://doi.org/10.1182/blood.V106.11.4331.4331

Published: 2005

Journal Articles

Leukemogenesis of the b2a2 Type p210 BCR/ABL in a Bone Marrow Transplantation Mouse Model Using a Lentivirus Vector.

Naoya Uchida, MD, Hideki Hanawa, MD, PhD, Koiti Inokuchi, MD, PhD, Kazuo Dan, MD, PhD, Takashi Shimada, MD, PhD

Blood (2005) 106 (11): 2875.

https://doi.org/10.1182/blood.V106.11.2875.2875

Published: 2005

Journal Articles

The DCC Heterozygote Reduces the Latency Period and Changes the Disease Phenotype of Myeloproliferative Disease in p230BCR/ABL-Expressing Mice.

Koiti Inokuchi, MD., PhD., Mituharu Inami, MD., Yazhu Wang, MD., Ayako Watanabe, MD., Hiroki Yamaguchi, MD., PhD., Sakae Tanosaki, MD., PhD., Takashi Shimada, MD., PhD, Kazuo Dan, MD., PhD

Blood (2004) 104 (11): 2968.

https://doi.org/10.1182/blood.V104.11.2968.2968

Published: 2004

Journal Articles

Identification and Hematopoietic Potential of CD45-Negative Clonal Cells with Very Immature Phenotype (CD45 − CD34 − CD38 − Lin − ) in Patients with Myelodysplastic Syndromes.

Kiyoyuki Ogata, MD, PhD, Chikako Satoh, MS, Mikiko Tachibana, MD, Hideya Hyodo, MD, Hideto Tamura, MD, PhD, Kazuo Dan, MD, PhD, Takafumi Kimura, MD, Yoshiaki Sonoda, MD, PhD, Takashi Tsuji, PhD

Blood (2004) 104 (11): 3426.

https://doi.org/10.1182/blood.V104.11.3426.3426

Published: 2004

NARROW

The Prognostic Impact Of Complex Gene Mutation In The Intermediate Risk Karyotype Acute Myeloid Leukemia

Inhibition Of S100A6 Induces Graft Versus Leukemia Effects In MLL/AF4-Positive ALL In Human PBMC-SCID Mice

B7-H1 Molecules on Myeloma Cells Induce Aggressive Cell Behavior

The Clinical Features and Prognostic Impact of DNMT3A Gene Mutation in Japanese Patients with De Novo AML

Gene Mutations in Paired Initial Presentation and Relapse Samples From Acute Myeloid Leukemia Patients,

MLL/AF4 Positive Acute Lymphoblastic Leukemia Has Resistance to Tumor Necrosis Factor-Alpha Caused by up-Regration of S100A6

The Activated K-RAS Protein Accelerates Human Derived-MLL/AF4 Induced Leukemo-Lymphomogenicity In Transgenic Mice Model

Identification and Functional Characterization of Telomerase RNA Variant Alleles in Japanese Patients with Aplastic Anemia or Myelodysplastic Syndrome.

Hematopoietic Differentiation of ES Cells from P230 Bcr/Abl Transgenic Mouse.

Leukemogenesis of the b2a2 Type p210 BCR/ABL in a Bone Marrow Transplantation Mouse Model Using a Lentivirus Vector.

The DCC Heterozygote Reduces the Latency Period and Changes the Disease Phenotype of Myeloproliferative Disease in p230BCR/ABL-Expressing Mice.

Identification and Hematopoietic Potential of CD45-Negative Clonal Cells with Very Immature Phenotype (CD45 − CD34 − CD38 − Lin − ) in Patients with Myelodysplastic Syndromes.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only